Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties
- PMID: 31202992
- DOI: 10.1016/j.ejmech.2019.06.016
Hydrogen sulfide donating ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane derivatives: Design, synthesis and antiproliferative properties
Abstract
Motivated by our interest in hydrogen sulfide bio-chemistry and ent-kaurane diterpenoid chemistry, 14 hydrogen sulfide donating derivatives (9, 11a-c, 12a-c, 13, 14, 16a-c and 17a-b) of ent-kaurane and spirolactone-type 6,7-seco-ent-kaurane were designed and synthesized. Four human cancer cell lines (K562, Bel-7402, SGC-7901 and A549) and two normal cell lines (L-02 and PBMC) were selected for antiproliferative assay. Most derivatives showed more potent activities than the lead ent-kaurane oridonin. Among them, compound 12b exhibited the most potent antiproliferative activities, with IC50 values of 1.01, 0.88, 4.36 and 5.21 μM against above human cancer cell lines, respectively. Further apoptosis-related mechanism study indicated that 12b could arrest Bel-7402 cell cycle at G1 phase and induce apoptosis through mitochondria related pathway. Through Western blot assay, 12b was shown to influence the intrinsic pathway by increasing the expression of Bax, cleaved caspase-3, cytochrome c and cleaved PARP, meanwhile suppressing procaspase-3, Bcl-2, Bcl-xL and PARP.
Keywords: Antiproliferative activity; Apoptosis; Diterpenoid; Hydrogen sulfide.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Hydrogen sulfide releasing oridonin derivatives induce apoptosis through extrinsic and intrinsic pathways.Eur J Med Chem. 2020 Feb 1;187:111978. doi: 10.1016/j.ejmech.2019.111978. Epub 2019 Dec 19. Eur J Med Chem. 2020. PMID: 31877536
-
Hydrogen sulfide releasing enmein-type diterpenoid derivatives as apoptosis inducers through mitochondria-related pathways.Bioorg Chem. 2019 Feb;82:192-203. doi: 10.1016/j.bioorg.2018.10.002. Epub 2018 Oct 8. Bioorg Chem. 2019. PMID: 30326401
-
The conversion of oridonin to spirolactone-type or enmein-type diterpenoid: synthesis and biological evaluation of ent-6,7-seco-oridonin derivatives as novel potential anticancer agents.Eur J Med Chem. 2012 Jun;52:242-50. doi: 10.1016/j.ejmech.2012.03.024. Epub 2012 Mar 23. Eur J Med Chem. 2012. PMID: 22483090
-
Bioactive Natural Spirolactone-Type 6,7-seco-ent-Kaurane Diterpenoids and Synthetic Derivatives.Molecules. 2018 Nov 8;23(11):2914. doi: 10.3390/molecules23112914. Molecules. 2018. PMID: 30413071 Free PMC article. Review.
-
Bioactive enmein-type 6,7-seco-ent-kaurane diterpenoids: natural products, synthetic derivatives and apoptosis related mechanism.Arch Pharm Res. 2018 Nov;41(11):1051-1061. doi: 10.1007/s12272-018-1078-3. Epub 2018 Sep 21. Arch Pharm Res. 2018. PMID: 30242610 Review.
Cited by
-
Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance.Genes Dis. 2020 Jul 5;8(4):448-462. doi: 10.1016/j.gendis.2020.06.010. eCollection 2021 Jul. Genes Dis. 2020. PMID: 34179309 Free PMC article. Review.
-
The potential role of hydrogen sulfide in cancer cell apoptosis.Cell Death Discov. 2024 Mar 6;10(1):114. doi: 10.1038/s41420-024-01868-w. Cell Death Discov. 2024. PMID: 38448410 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous